Subscribe to our blog
Posted 4 February 2020 by
Frederik Jaenen
VP of Sales @ Binocs

World’s First Innovation Centre Dedicated to Biopharma Operations Opens

The Biopharma 4.0 Alliance, led by Boston Consulting Group and NIBRT, have announced the opening of a new Innovation Centre to further bolster Europe’s biopharma expertiseBinocs has been selected to be involved in the B4.0 Alliance Innovation Centre, which showcases cutting-edge digital technologies that are considered to be key for the BioPharma industry.

Read the full press release below:


DUBLIN—Boston Consulting Group (BCG) and Ireland’s National Institute for Bioprocessing Research and Training (NIBRT), as part of the Biopharma 4.0 (B4.0) Alliance, have launched the world’s first innovation center fully dedicated to biopharma operations.

The innovation center showcases the latest Industry 4.0 (I4.0) technologies in biopharma manufacturing, quality control, and training excellence. These technologies are integrated with core operating processes to enable proof-of-concept use cases on new innovations and new ways of working, situated in an environment that simulates good manufacturing practice (GMP) standards.

The implementation of these technologies in the biopharma industry could lead to productivity improvements of up to 40%, especially when combined with lean methodologies. Whilst Europe has typically been a leader in biopharma innovation, the industry as a whole is behind other industries and the adoption of I4.0 technologies will help bridge the gap.

“Biopharma has traditionally lagged behind other industries in the adoption of cutting-edge technologies—often linked to a reluctance to introduce relatively ‘untested’ tech into the validated production environment. The B4.0 Alliance provides a safe GMP-like space to learn about, experience, and co-create digital use cases, quantify the value potential, and explore regulatory implications hands-on,” says Frank Cordes, Managing Director & Partner at BCG, and Operations practice lead for Western Europe. “We hope this center will encourage companies to experiment with new technologies and upskill talent, ensuring that the industry can accelerate the journey to value from I4.0.”

The innovation center allows visitors and alliance members to discover I4.0 technology and be inspired by biopharma-manufacturing-specific use cases. It also allows companies to co-create or pilot digital solutions to their specific challenges in a safe, GMP pilot environment.

The Alliance is a unique collaboration between leading players in the biopharma industry, select providers of innovative technologies, and industry experts from BCG and NIBRT.

“NIBRT has been delighted to work with BCG, our biopharma clients, and technology vendors to design and develop the Biopharma 4.0 Innovation Centre. This center provides a unique opportunity for the biopharma industry to test, assess, and develop proof-of-concept of leading 4.0 technologies with the potential to significantly increase efficiency in biopharma manufacturing. We look forward to the ongoing development of the center including the launch of our 4.0 training programs in 2020,” says Killian O’Driscoll, Director of Projects at NIBRT.

The Biopharma Innovation Centre

An illustration of the B4.0 Alliance Innovation Centre

The center, situated in NIBRT’s Dublin facility, is based on a B4.0 design blueprint produced last year, outlining how biopharma companies can use cutting-edge technologies such as artificial intelligence, dynamic scheduling, and augmented reality to revolutionize manufacturing operations. The blueprint contains a set of 90 key digital use cases prioritized by value. The current innovation center is divided into five rooms and demonstrates 30 of these key use cases, from a variety of suppliers.

The rooms:

  • Training Excellence: Be immersed in a virtual GMP facility, and be trained on technical operations and GMP behaviours.
  • Evolved Upstream: Experience the value that advanced analytics and machine learning can bring to process optimization, and see how technologies can help you deliver improved performance.
  • Advanced Fill Finish (New): See how simple sensors can be fitted to legacy production lines to give unparalleled visibility into performance.
  • Quality Control Lab of the Future: Schedule a lab in real-time and see how it reacts dynamically to changes through seamless integration with systems, providing live updates on the availability of samples and analysts.
  • Quality Assurance Centre of Excellence: Learn how data mining and the visualization of complex process dynamics can focus on improvement efforts, and see capacity planning and time management applied to QA.

For more information please visit https://connect.bcg.com/b4icolaunch/ or watch the Biopharma 4.0 Alliance video here.


About B4.0 alliance

The Biopharma 4.0 (B4.0) Alliance is a unique collaboration led by Boston Consulting Group (BCG) and the National Institute for Bioprocessing Research and Training (NIBRT). Formed in September 2018, it is made up of leading players in the biopharma industry, select providers of innovative technologies, and industry experts.


About National Institute for Bioprocessing Research and Training (NIBRT)

The National Institute for Bioprocessing Research and Training (NIBRT) is a global center of excellence for training and research in biopharmaceutical manufacturing. NIBRT is located in a world-class facility in Dublin, Ireland. This facility is purpose-built to closely replicate a modern bioprocessing plant with state-of-the-art equipment and enables NIBRT to offer the highest quality training and research solutions. NIBRT’s mission is to support the growth and development of all aspects of the biopharmaceutical manufacturing industry.


About Boston Consulting Group

Boston Consulting Group partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG was the pioneer in business strategy when it was founded in 1963. Today, we help clients with total transformation—inspiring complex change, enabling organizations to grow, building competitive advantage, and driving bottom-line impact.

To succeed, organizations must blend digital and human capabilities. Our diverse, global teams bring deep industry and functional expertise and a range of perspectives to spark change. BCG delivers solutions through leading-edge management consulting along with technology and design, corporate and digital ventures—and business purpose. We work in a uniquely collaborative model across the firm and throughout all levels of the client organization, generating results that allow our clients to thrive.


  • Scientists in white coats operate computers in a lab, illustrating the role of digitalization in biopharma process development labs

    3 key challenges for biopharma process development labs, and how digitalizing their lab helped them: a use case

    Find out how a multinational company who already used Binocs in QC labs also digitalized their biopharma process development labs with Binocs
    Read more
  • Bioreactors

    Small-scale production with Binocs

    Check out our blog post that briefly outlines how Binocs can successfully be leveraged to support small-scale (biopharma) production R&D projects
    Read more
  • Biopharma 4.0 and lab of the future- success

    Read more

Frederik Jaenen

Frederik is VP of Sales at Binocs and has over 25 years of experience in laboratory systems, including as a Project Manager for major LIMS rollouts at various global enterprises. When he joined Bluecrux in 2017, his experience and business development skills significantly boosted the commercial success of Binocs.